4876-14-6 Usage
Uses
Used in Pharmaceutical Research and Development:
DL-3-(1,2-Dihydro-2-oxo-quinoline-4-yl)alanine hydrochloride is utilized as a research compound for the development of new drugs and therapies. Its unique structure and properties make it a promising candidate for the treatment of various diseases and conditions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, DL-3-(1,2-Dihydro-2-oxo-quinoline-4-yl)alanine hydrochloride is used as a key intermediate in the synthesis of novel compounds with potential therapeutic applications. Its ability to be modified and combined with other molecules allows for the exploration of new chemical entities with improved pharmacological profiles.
Used in Drug Discovery:
DL-3-(1,2-Dihydro-2-oxo-quinoline-4-yl)alanine hydrochloride is employed as a starting material in drug discovery processes. Its potential applications in the treatment of various diseases make it an important compound for screening and optimization to identify new lead compounds and drug candidates.
Used in Chemical Synthesis:
DL-3-(1,2-Dihydro-2-oxo-quinoline-4-yl)alanine hydrochloride is also used in chemical synthesis for the preparation of other quinoline-based derivatives with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 4876-14-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,8,7 and 6 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 4876-14:
(6*4)+(5*8)+(4*7)+(3*6)+(2*1)+(1*4)=116
116 % 10 = 6
So 4876-14-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2O3.ClH/c13-9(12(16)17)5-7-6-11(15)14-10-4-2-1-3-8(7)10;/h1-4,6,9H,5,13H2,(H,14,15)(H,16,17);1H/t9-;/m0./s1
4876-14-6Relevant articles and documents
Preparation method of rebamipide bulk drug
-
Paragraph 0012; 0029; 0034; 0038; 0043; 0047; 0052, (2021/08/14)
The invention discloses a preparation method of a rebamipide bulk drug. The preparation method comprises the following steps: 1, preparing a crude product of the rebamipide bulk drug: preparing the crude product of the rebamipide bulk drug by utilizing a compound III and 4-chlorobenzoyl chloride; and 2, purifying the rebamipide bulk drug. The compound III is prepared from a compound II, deionized water and concentrated hydrochloric acid, the compound II is prepared from a compound I, glacial acetic acid and concentrated hydrochloric acid, and the compound I is prepared from diethyl acetamidomalonate and 4-bromomethylquinolone. A process control method is utilized, impurities in the synthesized compound I, impurities in the synthesized compound II and impurities in the synthesized compound III are respectively subjected to impurity removal and purification by a common purification method, and the purity of the rebamipide bulk drug is improved in combination with a method for crystallizing and purifying the crude product of the rebamipide bulk drug.